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Abstract 
Curcumin is a natural active constituent of Curcuma longa from Zingiberaceae family that shows many different pharmacological 
effects such as anticancer, antioxidant, anti-inflammatory, antimicrobial and antiviral effect. However, its bioavailability is profoundly 
limited by its poor water solubility. In this study antisolvent crystallization followed by freeze drying was used for the preparation of 
curcumin nanoparticles. The presence of different ratios of hydrophilic polymers (poloxamer 188 & soluplus) on physicochemical 
properties of curcumin nanoparticles was also investigated. In addition, the effect of high pressure homogenization (HPH) on 
solubility and dissolution properties of curcumin was investigated. All nanoparticle formulations were examined to determine their 
particle size distribution, saturation solubility, morphology (SEM), solid state (DSC, XRPD and FT-IR) and dissolution behavior. It 
was observed that curcumin crystallized in the presence of polymers exhibited better solubility and dissolution rate in comparison with 
original curcumin. The results showed that the concentration of the stabilizer and the method used to prepare nanoparticles can control 
the dissolution of curcumin. The crystallized nanoparticles showed polymorph 2 curcumin with lower crystallinity and higher 
dissolution rate. Curcumin nanoparticles containing 50% soluplus prepared via HPH method presented 16-fold higher solubility than 
its original form. In conclusion, samples crystalized and proceed with HPH technique showed smaller particle size, better re-
dispersibility, higher solubility and dissolution rate in water compared with a sample prepared using a simple antisolvent 
crystallization process.   
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1. Introduction: 
Curcumin, a polyphenol, is a yellow-orange pigment extracted from the powdered rhizomes of turmeric. Curcuminoids are only a 
small fraction of the turmeric rhizome and Curcumin compromises approximately 77% of the curcuminoid content.  It is assumed that 
the major components of the commercial products are 77% curcumin, 17% dimethoxycurcumin and 3% bisdemethoxycurcumin with 
variances. It has been shown that Curcumin has a wide range of activities such as antioxidant, anti-inflammatory, antimicrobial, and 
anticarcinogenic activities (Goel et al., 2008). 
Despite these medicinal benefits, curcumin shows a low oral bioavailability due to its poor aqueous solubility (11ng/ml at pH 5.0) and 
dissolution properties which greatly restricted its therapeutic use (Mohanty and Sahoo, 2010; Sanphui et al., 2011). Several strategies 
have been used to overcome this problem such as preparation of solid dispersion formulations (Li et al., 2015; Seo et al., 2012), use of 
polymeric nanoparticles (Beloqui et al., 2014; Fares and Salem, 2015), solid lipid nanoparticles (Kakkar et al., 2013; Sou et al., 2008), 
the use of micelles (Abouzeid et al., 2014; Song et al., 2014) and cyclodextrins (Tønnesen et al., 2002).  
Among these methods reduction of particles to nanometer range could enhance both solubility and dissolution rate due to changes in 
the particle behavior proved by the Ostwald–Freundlich equation (Kesisoglou et al., 2007). There are two main techniques to 
manufacture nanoparticles (a) top-down and (b) bottom-up methods. In top-down techniques basilically equipment such as mill and 
high pressure homogenization (HPH) are used to reduced the size of particles (Shegokar and Müller, 2010; Van Eerdenbrugh et al., 
2008), whereas in bottom-up techniques, nanoparticles can be obtained by molecular arrangement process such as precipitation or 
crystallization to control the size of nanoparticles (Sinha et al., 2013). Although, there are many techniques in bottom-up method to 
make nanoparticles, percipitation by the addition of non-solvent has been the most favorable method. In this system simply the drug is 
  
dissolved in an organic solvent followed by the addition of an antisolvent (which is miscible with the solvent used to dissolve the 
drug) to precipitate the drug. One of the main problems with this technique is the crystal growth of particles after the precipitation. To 
overcome the crystal growth, generally, a stabilizer is added to the crystallization medium. The presence of the stablizer also inhibits 
the aggregation of nanoparticles. Furthermore, the case of using a hydrophilic stabilizer the wettability of hydrophobic drugs increased 
and this inturn can improve the solubility and oral bioavailability (Sinha et al., 2013; Thorat and Dalvi, 2012). This process is very 
popular as apart from improving the dissolution rate it can improve other pharmaceutical physicomechanical properties such as 
flowability and compressibility (Nokhodchi et al., 2015). On the basis of this, Baxter pharmaceutical company has invented a 
combination technology called ‘NANOEDGE”. In this method precipitated nanoparticles are subjected to high pressure homogenizer 
in order to inhibit the crystal growth and break down the large agglomerates (Rabinow, 2004). In addition to these attempts, the 
conditions of crystallization environment e.g. type of solvent, the ratio of solvent to antisolvent, the agitation of mixing etc. could 
affect the physicochemical properties of precipitates (Thorat and Dalvi, 2012). 
In recent years many studies have been carried out to produce nanoparticles of curcumin by antisolvent crystallization, however, to the 
best of our knowledge, there is no specific study on the effect of soluplus and poloxamer as a stabilizer in nanoparticles of curcumin. 
In other words, the aim of this study is to investigate the effect of different ratios of soluplus and poloxamer on curcumin 
nanoparticles prepared by antisolvent crystallization. Moreover, in this study, the effect of high pressure homogenization on obtained 
nanosuspensions has been investigated. Although there are a few studies investigated the effect of antisolvent crystallization, HPH and 
freeze-drying, in each study only one method was used under different conditions and it is very difficult to justify the results obtained 
when comparing different methods published in different studies. There is no systematic and comprehensive study to investigated 
antisolvent, high pressure homogenization and freeze-drying together in a single study. Therefore, in the current study all three 
methods (antisolvent, HPH and freeze-drying) were employed on curcumin in a single study and the results can be elaborated better 
compared to previous study to enhance the dissolution rate of curcumin.   
 
  
2. Materials and methods 
2.1. Materials 
Curcumin (Mitushi Biopharma, India), poloxamer 188 (Sigma, Germany), soluplus (BASF, Germany), and sodium dodecyl sulfate 
(Merck, Germany) were obtained. All other solvents and chemicals were of analytical grade. 
 
2.2. Methods 
2.2.1. Preparation of CUR:SOL and CUR:POL freeze dried nanoparticles precipitated by antisolvent crystallization method 
(CRS-FD) 
Twenty milliliters of acetone was used to dissolve 1 g Curcumin. Various amounts of SOL or POL188 (0, 0.05, 0.1, 0.25 and 0.5 g) 
was separately dissolved in beakers containing 200 ml distilled water. The acetone solution containing curcumin was added dropwise 
(at a rate of 5 ml/min) using a burette into the aqueous solution with varying concentrations of the polymers stirring at 600 rpm at 25 
°C to achieve various ratios of Curcumin:polymer (1:0, 20:1, 10:1, 4:1 or 2:1). The final suspension was immediately freezed at −70 
°C followed by freeze drying (Martin Christ freeze dryer, Germany) for 48 h. Each crystallization experiment was performed in 
triplicate. 
 
2.2.2. Preparation of CUR:SOL and CUR:POL freeze dried nanoparticles precipitated by antisolvent crystallization method 
followed by high pressure homogenizer (HPH-FD) 
A FBF laboratory high pressure homogenizer (Italy) was used to process further the suspensions obtained from the antisolvent 
crystallization (CRS) process. The applied pressure was set at 500 and 1000 bars for 5 and 10 cycles respectively. The final 
suspension obtained after applying HPH was immediately freeze dried at −70 °C for 48 h. Each experiment was performed at least 
three times. The protocol used in the current research was based on the previously published articles elsewhere (Homayouni et al., 
2014a;2014b). 
  
 
2.2.3. Preparation of physical mixtures of drug carrier (PM) 
In order to have a better comparison between the processed formulation and unprocessed formulations, physical mixtures of CUR and 
stabilizers were prepared as counterpart (the same ratios as the treated formulations were used) To this end, CUR, SOL or POL were 
sieved to get particle size fractions of less than 250 µm followed by mixing of CUR with SOL or POL using mortar and pestle for 2 
min. The 2 min was good enough to get a good uniformity. The formulations were kept in well-tight containers until further use. 
 
2.2.4. Morphological analysis 
The morphology of nanosuspensions was examined using an optical microscope (OM) (Olympus BX-60, Japan) before freeze drying. 
In addition to the optical microscope, SEM images of the freeze dried particles were obtained using a scanning electron microscope 
(Philips X series, Netherlands) with an acceleration voltage of20 kV.  
 
2.2.5. Particle size measurement 
A nano-zetasizer (Malvern, UK) was employed for the measurement of the particle size of precipitates obtained via both CRS and 
HPH techniques. To do this end, deionized water was used the obtained nanosuspensions to get the concentration around 1 mg/ml. 
The measurements were carried out in triplicate and their mean and standard deviation of Z-average size and zeta potential of the 
particles were calculated. 
  
2.2.6. Determination of saturation solubility 
The saturation solubility of pure CUR, physical mixtures of CUR:SOL/POL and freeze dried samples obtained via different methods 
were determined according to the method published elsewhere (30). Briefly, around 2mg CUR was dispersed in 10 ml double-distilled 
  
water in a beaker followed by agitation at 200 rpm at 25 °C for 48 h. The suspensions were then filtered through a 0.22 µm filter (MS
®
 
Nylon Syringe Filter) and then the concentration of the filtered suspension was measured at 426 nm (Shimadzu, Japan).  
 
 
2.2.7. Differential scanning calorimetry (DSC) 
DSC traces of the formulations was carried out using DSC 822e (Mettler Toledo, Switzerland) equipped with a refrigerated cooling 
system. Few of the samples which were vital in the current research were selected to determine their thermal behavior. In brief, few 
mg of the samples (2-3 mg) were placed in aluminum pans and sealed with a lid. The DSC pan containing the sample was scanned at a 
rate of 10 °C/min between 20 and 200 °C. The experiment was run under nitrogen gas at a flow rate of 80 ml/min. The thermal 
behaviors of the samples such as onset temperatures, melting points and endothermic and exothermic enthalpies were determined 
using the software provided (STARe Ver. 12.00 Mettler Toledo, Switzerland). 
 
2.2.8. X-ray powder diffraction studies (XRPD) 
The crystal state of the formulations was analyzed using XRPD. Scanning were carried out on selected samples using a D8 Advance 
diffractometer (Bruker, Germany) with Cu Kα radiation (λ = 1.54 Å) with scanning range of 5–80° (2Ɵ) with a step size of 0.05. 
 
2.2.9. Fourier transform infrared spectroscopy (FT-IR) 
As Curcumin may go under molecular changes during the crystallization, FT-IR (WQF-510/520 FTIR spectrophotometer, China) was 
used to study the changes in the molecular level of CUR in the formulations obtained. 
Samples were prepared by potassium bromide (KBr) at a ratio of 1:10 and scanned against a blank KBr disk ranging from 4000 to 450 
cm
-1
 with resolution of 1.0 cm
-1
. 
 
  
2.2.10. Dissolution studies 
The dissolution behavior of curcumin formulations were examined using a USP dissolution apparatus, 2, paddle method (Pharmatest, 
Germany). The amount of dissolution medium (distilled water containing 0.25%w/v sodium dodecyl sulfate) in each vessel was 1000 
ml which equilibrated to 37 °C with the paddle rotation of 50 rpm. Curcumin formulations equivalent to 10 mg CUR was placed at the 
top of the dissolution medium. At different time intervals, 5 ml of the dissolution medium was withdrawn and replaced by 5 ml fresh 
dissolution medium. The withdrawn solution was immediately filtered through 0.22 µm cellulose ester filter (MS
®
 Nylon Syringe 
Filter) followed by reading the absorbance of the solution at a wavelength of 426 nm by spectrophotometer (Shimadzu, Japan). The 
concentration of the solution was then calculated on the basis of a calibration curve obtained for CUR at this wavelength. The 
dissolution was repeated 3 times for each formulation.  
 
2.2.11. Dissolution parameters 
For a better understanding and comparison on dissolution profiles, the dissolution efficiency (DE) and mean dissolution time (MDT) 
were determined using the following equations. In equation 1, DE represents the area under the dissolution curve (y) up to a certain 
time t, expressed as a percentage of the area of the rectangle described by 100% dissolution in the same time.  
 
Equation 1 
 
 
Equation 2 represents MDT and it reflects the mean time of dissolution. In equation 2 

t
i define the midpoint of the time period during 
which the fraction ΔM of the drug has been released from sample.  
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Equation 2 
 
2.2.12. Re-dispersibility in water 
In this test simply the powder was put on the surface of distilled water in a beaker and the re-dispersion of samples recorded 
photographically after 3 seconds. 
Although the dissolution studies provide suitable results and indirectly shows how fast the particles could be dispersed and being wet 
in water, however this test has been done to illustrate visually and supports the dissolution results.  
 
2.2.13. Statistical analysis 
Statistical analysis was performed by one way analysis of variance (ANOVA) using Graph Pad Prism software (version 6.07). For all 
of the tests, the differences were considered as statistically significant where P < 0.05. 
 
3. Results and discussion 
Antisolvent crystallization is a simple and effective method to produce micro/nanoparticle of poorly water soluble drugs in order to 
improve its dissolution rate. In this study acetone and water have been used as a solvent and antisolvent for curcumin respectively. 
Among different solvents which can dissolve curcumin, acetone known as the best one because of high solubility and stability of 
curcumin in it and in addition this solvent could be evaporated as well at low temperature. Distilled water used as antisolvent because 
of its safety and cost-effectivness. In this study Soluplus and poloxamer 188 were used as stabilizer in order to inhibit crystal growth 
of curcumin.  Moreover these carriers could accelerate wettability of curcumin simply because of their amphiphilic structures.    
  
In section 2.2.2, the main reason to employ 5 cycles with 500 bars pressure was to pretreat suspension and it is important to use low 
pressure in HPH method to mill and breakdown the particles to achieve smaller particles. In addition, higher pressure at the first step 
could lead to aggregation of particles and blockage of the orifice of high pressure homogenizer. 
 
3.1. Morphological analysis  
Morphological analysis was performed in order to investigate the effect of crystallization techniques on the morphology of curcumin. 
Therefore, OM was used to investigate as an online scanning procedure. In this study, the effect of different ratios of stabilizers and 
also the effect of high pressure homogenization on morphology of particles after crystallization were investigated. In addition, 
scanning electron microscopy could illustrate the crystal habit of particles after freeze drying.    
As shown in Fig. 1A. Freshly crystallized CUR without any stabilizer exhibited large aggregated particles while samples crystalized 
with different ratios of stabilizers (SOL or POL) showed very small and homogenous spherical particles (Fig. 1B with 5% soluplus).  
To explore the effect of high pressure homogenization on the morphology of particles containing CUR, high pressure homogenizer 
was employed to produce nanosuspension with smaller particle size. Interestingly the sample subjected to the HPH produced larger 
particles with different morphologies. Figure 1C shows that HPH technique could break down the obtained spherical particles during 
homogenization. The formation of spherical particles in CRS samples could be attributted to the creation of temporary nanoemulsion 
droplets (quasi-emulsion) followed by the precipitation of the nanocrystals inside the droplets as a result of the counter-diffusion of 
the good solvent (acetone) and poor solvent (water) out and into the emulsion droplets respectively (Pignatello et al., 2002a; Pignatello 
  
et al., 2002b; Pignatello et al., 2006). Similar results have obtained with antisolvent crystallization of celecoxib and PVP in our 
previous study (Homayouni et al., 2014c).  
It can be concluded that the HPH method could change the morphology of CUR-CRS samples (Fig. 1C). During the homogenization, 
spherical temporary nanoparticles could be broken down by cavitation mechanism and this process could change the morphology of 
nanoparticles. As described before the nanospheres obtained with QESD (Quasi-emulsion solvent diffusion) method are unstable and 
could be destroyed by an aggressive procedure like HPH. This condition could be occurred also when these nanosuspensions were 
freeze dried. The freeze-dried samples were shown in Fig 2. CUR:SOL5% CRS-FD samples exhibited plate-shape particles as shown 
in Fig. 2B. These particles change to particles with similar –crystal habit after HPH process followed by freeze-drying (HPH-FD 
samples). However, it seems CUR:SOL5% HPH-FD presented lower mean particle size (Fig 2C). Similar results have been obtained 
with CUR:POL5% CRS-FD samples. In these samples, rod-shaped particles have been obtained (Fig 2D) whereas those formulations 
manufcatured uisng antisolvent crystallization and HPH followed by freeze drying (HPH-FD) exhibited smaller particles with platy 
morphology (Fig 2E). Different crystal habits was also reported elsewhere (Thorate and Dalvi, 2015) where CUR could crystallize in 
three polymorphic forms. Form 1 (monoclinic structure) whereas Forms 2 and 3 exist as orthorhombic structures. Liquid antisolvent 
crystallization of CUR with additive and/or ultrasound resulted orthorhombic forms (Form 2 or Form 3) with different crystal habits 
(depending on each additive used) while crystallization of CUR without any additive or ultrasound produce monoclinic form with star-
like crystal. In another study Yadav and Kumar (2014) prepared nanoparticle of CUR by antisolvent crystallization. The freshly 
crystallized CUR with and without any additive showed spherical nanoparticles however these nanoparticles converted to star-like 
crystal after 1.5 hour and after 3 hours these crystals aggregate together to form platy-shape crystals. While the spherical nanoparticle 
obtained with 0.5% Gelatin (as stabilizer) could retain its shape after 3 hours (Yadav and Kumar, 2014).  
 
3.2. Particle size measurement  
  
Particle size measurement was performed to investigate the effect of different stabilizers and also various ratios of them on the mean 
particle size of the formulations. Moreover, the effect of processing method (HPH and freeze drying) has been studied for this section.  
The results in Table 1 showed that the particles obtained through the antisolvent crystallization technique (CRS) showed smaller 
particle size compared to the HPH technique. Statistical analysis showed this difference is significant (p < 0.05). Moreover, in general, 
the PDI of these samples become higher after HPH process. As described in optical microscopy section, when CRS samples subjected 
to high pressure homogenizer, the unstable nanoemulsion droplets of CUR/stabilizer could be brokenen down during HPH process and 
then an increase in the size of particles obtained.  
Comparing of freeze dried samples (CRS-FD and HPH-FD) with non-freeze dried samples (CRS and HPH) showed that the mean 
particle size of these samples become greater (p < 0.05) that could be predictable. By freezing the water and sublimation of ice, the 
freely mobilize particles in suspension could aggregate together; hence re-dispersion of these particles could not simply happen after 
freeze drying so generally the mean particle size of freeze dried samples is greater than non-freeze dried samples.   
The interesting result in Table 1 is the comparison of mean particle size of HPH-FD samples with CRS-FD ones. As described before 
the mean particle size of samples obtained via CRS was smaller than the samples obtained via HPH method, while in freeze dried 
samples the mean particle size of HPH-FD was smaller than CRS-FD samples. Moreover, generally the PDI of HPH-FD samples are 
smaller than PDI of CRS-FD samples. This result shows the ability of HPH process to generate particles with more dispersability after 
freeze drying. The CRS samples showed smaller particle size than samples produced by HPH method (without any freeze drying). 
However these small particles in both CRS and HPH methods are not stable enough and could be disturbed and aggregated if they 
were subjected to any aggressive conditions such as freeze-drying. When the both samples (CRS and HPH) were freeze-dried it seems 
the particles produced by CRS have more tendency to aggregate due to having smaller particle size and larger surface area compared 
to HPH samples. Therefore, the aggregation in CRS samples should be much higher and stronger than HPH samples (due to 
differences in their particle size). When the particle size is measured for freeze-dried samples the force applied to deaggregate the 
particles is not good enough, therefore, samples obtained via CRS-FD should be larger than the samples obtained via HPH-FD. This 
  
indicates that larger particles of curcumin is less influenced by freeze-drying process compared to smaller curcumin particles which 
could be an advantage for HPH method used in the current research. This was also supported by the fact that high pressure 
homogenizer (HPH method) could produce nanocrystals with narrow PDI with a suitable re-dispersibility (Keck and Muller, 2006.) 
 
Comparing of the mean particle size of the samples prepared with SOL or POL showd no remarkable results nor for different ratios of 
carriers.    
 
3.3. Determination of saturation solubility  
The saturation solubility analysis was performed on pure CUR, physical mixtures (PM), CRS-FD and HPH-FD samples. The 
solubility study of raw CUR showed very low solubility in distilled water (0.18 µg/ml), although the solubility has been improved in 
crystallized and homogenized pure CUR, however this enhancement was not significant (p > 0.05). As shown in Fig. 3 the presence of 
stabilizers increased the solubility of CUR in PM, CRS-FD and HPH-FD samples. This enhancement in the solubility became greater 
by increasing the stabilizer contribution in the formulations that could be attributed to the solubilizing effect of SOL and POL as the 
amphiphilic polymers. SOL and POL could generate micelles in water and dissolve the CUR molecules. These stabilizers with 
hydrophilic groups along with the lipophilic chain are able to interact with hydrophobic drugs and finally accelerate the hydration of 
poorly-water soluble drugs (Homayouni et al., 2014a; Homayouni et al., 2015). Comparison of solubility data -among PMs and 
crystallized samples (CRS-FD and HPH-FD) demonstrated that HPH-FD formulations in the presence of SOL or POL have been more 
effective in enhancing the solubility of CUR than PM and CRS-FD samples. Statistical analysis showed that all HPH-FD samples 
showed higher saturation solubility compare to PM and CRS-FD samples (p < 0.05). for instance, the saturation solubility of CUR in 
CUR:SOL 50% HPH-FD sample was 2.96 µg/ml while this amount was 0.59 µg/ml and 0.49 µg/ml for CRS-FD and PM samples 
respectively. Although the CRS-FD samples showed higher solubility compared to its physical mixtures, however, high pressure 
homogenization followed by antisolvent crystallization could be more effective than simple antisolvent crystallization technique. It 
  
seems the method of preparation plays a critical role on saturation solubility of CUR in these samples. The higher solubility of HPH-
FD samples compared to other samples could be due to the smaller mean particle size of these samples. According to Table 1, 
generally, HPH-FD samples in the presence of SOL or POL in different ratios showed smaller particles size with narrower PDI.  
 
3.4. Differential scanning calorimetry (DSC) 
In order to investigate any interaction between drug and stabilizers, DSC analysis has been performed. In addition, any changes in the 
polymorphic form of CUR and also in the generation of amorphous state of CUR during crystallization process could be detected 
through this thermal analysis. Fig 4 shows the DSC traces of untreated CUR, physical mixture samples with 50%SOL and 50%POL 
and also crystallized samples with the same ratios. The untreated CUR exhibited an endothermic peak near 176 °C corresponding to 
its melting point which reported previously in literature data (Donsì et al., 2010; Kakran et al., 2012; Sanphui et al., 2011). CUR 
samples crystallized in the absence of any stabilizers (CUR CRS-FD) exhibited a different pattern in its thermogram. This sample 
showed two endothermic peaks near 162 °C and 157 °C. Comparison of DSC traces of untreated CUR and CUR CRS-FD sample 
indicated the presence of new polymorph during the crystallization process. Moreover, the enthalpy of fusion reduced from 82 J/g for 
untreated CUR to 74 J/g for CUR CRS-FD sample. This reduction confirmed the reduced crystallinity of curcumin during the 
crystallization process. Previous studies have also reported the possibility of the presence of different polymorphic forms of curcumin 
during crystallization (Sanphui et al., 2011; Thorat and Dalvi, 2014; Thorat and Dalvi, 2015). Kakran and Sahoo (2012) prepared CUR 
by antislovent crystallization with ethanol and water as solvent and antisolvent respectively however the DSC trace of crystallized 
CUR were similar to raw CUR (Kakran and Sahoo, 2012). As describe before it seems the condition of crystallization could affect the 
solid state of crystalized CUR.    
CUR:SOL 50% PM sample showed the melting endothermic peak of curcumin near 176 °C, however the intensity of peak reduced 
and broadened. In CUR:POL 50% PM a large endothermic peak appeared near 55 °C corresponded to the melting point of poloxamer 
188. The absence of CUR melting endothermic peak in this sample is attributed to the dissolution of CUR in the molten POL. In 
  
CUR:POL 50% CRS-FD sample similar result was obtained. Reduction in the melting point of POL to 55 °C could be attributed to the 
penetration of CUR molecules into the crystalline structure of POL during crystallization. As a result, POL present lower crystalline 
structure, compared to its primary form. Therefore, it could be melted at a lower temperature with broad melting peak. A similar 
condition could occur for CUR. Reduction in CUR melting point to lower temperature with broader peak and lower intensity exhibited 
the formation of a matrix between CUR and POL. In the crystallized sample prepared with 50% SOL similar result was obtained. In 
CUR:SOL50% CRS-FD the peak intensity of CUR melting point was reduced to 166 °C with an enthalpy of fusion 16 J/g compared 
to its physical mixtures with 33 J/g value. This result indicates that most part of CUR present in amorphous nature in this sample. 
Similar results have been reported for celecoxib with solplus and poloxamer (Homayouni et al., 2014a; Homayouni et al., 2014b).   
 
3.5. X-ray powder diffraction studies (XRPD) 
The results of XRPD studies are depicted in Fig.5. X-ray diffraction of CUR showed sharp peaks at 2Ɵ values of 9.15°, 10.3°, 14.2°, 
16.9°, 20.1° and 21.1° which is an indication of crystalline state of curcumin. As shown in Fig 5, CUR-CRS sample showed similar 
pattern to CUR but with smaller intensity that could be due to the lower crystallinity of the treated sample. Moreover, in CUR CRS-
FD sample, the presence of a new peak at 16.2° demonstrated the existence of a new polymorphic form of curcumin in this sample. 
Previous studies have been reported the probability of curcumin polymorph formation during crystallization (Sadeghi et al., 2016; 
Thorat and Dalvi, 2014; Thorat and Dalvi, 2015).  It seems CUR CRS-FD sample contains both amorphous and polymorphic forms of 
curcumin. Comparison the XRPD pattern of the samples obtained via CRS-FD and HPH-FD did not show any significant difference 
which proved that the HPH process did not change the solid state of curcumin. Although, a reduction in the peak intensity of CUR-
SOL50% HPH-FD and CUR-POL50% HPH-FD could be an indication of a reduction in crystallinity of curcumin in these samples, 
the presence of a new peak at 16.2° indicating the mixture of amorphous and polymorphic form in the sample. The PXRD result also 
supported the DSC findings for the  crystallized samples.  
 
  
3.6. Fourier transform infrared spectroscopy (FT-IR) 
FT-IR was also used to study the molecular interactions between the CUR and the stabilizers. Moreover, FT-IR study could exhibit the 
amorphous nature and the presence of any polymorphism of curcumine. The FT-IR spectrums of untreated curcumin, CUR-CRS and 
crystalized samples prepared with 50% stabilizer were showed in Fig 6. Untreated curcumin showed a characteristic peak at 1628 cm
-1
 
corresponded to its carbonyl group participate in intramolecular hydrogen bonding. It has been demonstrated that curcumin exhibits 
keto-enol tautomerism. Single crystallography analyses have shown that the most favorable form of curcumin is the keto-enol form 
(Sanphui et al., 2011). Resonance-assisted intramolecular hydrogen bond stabilized this conformation. Formation of an intramolecular 
hydrogen bond leads to change of wave number of the carbonyl stretching band from 1700 cm
-1
 to 1628 cm
-1
. The CUR-CRS sample 
showed the same band at 1628 cm
-1 
indicating that the intramolecular hydrogen bonded keto-enol tautomer exists in this sample too. 
Moreover it has been reported before that crystalline curcumin (form 1) participate in intramolecular hydrogen bonds between the 
phenolic groups and methoxy substituents, oriented ortho to one another on the phenyl ring (Wegiel et al., 2014). With these 
conditions possibility of hydrogen bonding between curcumin and a polymer will be weak. As reported in literatures, untreated 
curcumin (form 1) showed characteristic peaks at 1628 cm
-1
 attributed to carbonyl group (described above), at 1601 cm
-1 
belong to 
aromatic C=C stretching, at 1429 cm
-1 
due to phenolic C-O stretching, at 1281 cm
-1 
due to enolic C-O stretching  and a sharp peak at 
3508 cm
-1 
which is attributed to OH stretching (Sanphui et al., 2011). These wavenumbers for crystalline curcumin (form 1) is 
compatible with our untreated CUR as shown in Fig 6, but in CUR-CRS sample some of these peaks have been shifted. The OH 
stretching bond has been changed from 3508 cm
-1
 to 3406 cm
-1
 and 3259 cm
-1
. Moreover, the C=C aromatic stretching at 1601 cm
-1 
bifurcated to 1601 cm
-1 
and 1587 cm
-1
. In addition, the phenolic C-O stretching at 1281 cm
-1 
bifurcated also to and 1281 cm
-1
 and 1263 
cm
-1 
(Fig 6B). All these changes demonstrated the formation of new polymorph during crystallization. Sanphui et al reported these 
changes previously in FT-IR spectrum that could be due to the presence of polymorph 2 in curcumin. They are also reported that in 
form 2, curcumin is less crystalline compared to form 1 or the content of amorphous in form 2 is higher than other polymorphs 
  
(Sanphui et al., 2011). In conclusion, all the above descriptions proved that CUR-CRS sample contains polymourph 2. These results 
supported the DSC and XRPD findings.   
As described above it might be projected that curcumin hydrogen bonding with a stabilizer could occur between phenolic OH group of 
curcumin and an electronegative group of a carrier. As shown in Fig 6 SOL showed large and broad spectrum at 1643 cm
-1
 and 1739 
cm
-1
 corresponding to tertiary amide and ester carbonyl stretching respectively. However, according to a large number of C=O group 
of SOL compared to OH groups of CUR it could not simply show the formation of hydrogen bonding with FT-IR spectrum. In other 
words, in case of hydrogen bonding, the number of non-bonded C=O groups are more than carbonyl group which participate in 
hydrogen bonding. Therefore this results leads to a negligible shift in the C=O stretching vibration band. The changes in OH groups 
position of curcumin and broadening the peaks might be due to the presence of curcumin in amorphous nature (Sanphui et al., 2011) 
or formation of hydrogen bond between curcumin and soluplus. FT-IR spectrum of poloxamer 188 and curcumin did not add useful 
results.  
 
3.7. Dissolution studies 
The dissolution pattern of original CUR and treated samples are shown in Fig. 7. For comparison purpose the dissolution profile of 
physical mixtures of curcumin and polymers (PM) were plotted and shown in Figures 7A and B.  The results showed that the presence 
of POL or SOL enhanced the disolution rate of curcumin and this enhancement become more apparent when the concentration of the 
stabilizers increased (Fig. 7A and B). The increase  in the dissolution is due to hydrophilic nature and surfactant properties of the 
stabilizers which could accelerate the hydration of lipophilic drugs as discussed before in the saturation solubility section. It can be 
concluded that the presence of POL or SOL is useful to improve the dissolution rate of curcumin. It was interesting to note that  the 
dissolution rate of curcumin can be further increased by treating the samples via crystallizations or HPH methods (Figs. 7C, D, E and 
F). The reason for the further enhancement in the dissolution could be due to the smaller particle size in these samples compared to 
their PM counterpart. Moreover, in these samples during crystallization process, stabilizer (POL or SOL) could attach to the surface of 
  
curcumin particles during crystal growth and inhibit the aggregation of nanoparticles.  As shown in Figs. 7C and D the dissolution 
enhancement become accelerated by increasing the polymer ratios. It is obvious that increasing the polymer ratio could accelerate the 
dissolution rate of CUR because of the surfactant properties of the polymers (both POL and SOL). Moreover these carriers could act 
as stabilizer so the higher ratios of polymers could be more effective to inhibit the crystal growth of CUR particles during the 
crystallization process. These results can be backed up by few references (Homayouni et al., 2014b; Homayouni et al., 2014c; Sinha et 
al., 2013; Thorat and Dalvi, 2012). Comparing the dissolution profiles of samples obtained via CRS for both POL and SOL showed 
that SOL formulations showed slightly faster dissolution compared to POL formulations. For instance, CUR:SOL50% CRS-FD 
showed about 80% dissolution after 40 minutes while this value was 62% for CUR:POL50% CRS-FD sample at the same time. The 
results also showed that, generally, samples obtained through HPH showed higher dissolution rate compared to the samples obtained 
through CRS method. The results of percentage dissolution efficiency (DE) and mean dissolution time (MDT) also demonstrated these 
findings (Table 2). In HPH-FD samples with higher concentration of polymer almost all of curcumin released after 40 min. for 
example in CUR:POL50% HPH-FD sample 98% of curcumin released after 40 min while this value is 68% after 40 min for 
CUR:POL50% CRS-FD sample. The reason for this phenomenon could be due to having the smaller particle size for HPH-FD 
samples compared to CRS-FD samples (Table 1 and Fig. 2).  The results obtained from table 2 and figure 7, demonstrated the better 
performance of particles obtained through HPH-FD compared to CRS-FD samples particularly at lower concentration of stabilizer. 
These results are in line with the saturation solubility studies.  Comparing the dissolution efficacy and dissolution profile data 
(reported in Table 2 and Fig 7) between CRS-FD and HPH-FD samples showed that at high concentration of polymer (50%), HPH 
process does not show impressive effect on DE% (table 2) while at low concentration of polymer (both POL and SOL) methods of 
manufacture and effect of HPH process, play a critical role on dissolution enhancement of curcumin. In the other word at high 
concentration ratio of stabilizer the dissolution rate depended on polymer ratio and HPH process could not show its effect as well as at 
low concentration ratios of stabilizer (5%, 10% and 25%). Several studies have been demonstrated the high efficiency of HPH process 
for enhancing the dissolution rate of several drugs (Donsì et al., 2010; Keck and Muller, 2006; Shegokar and Müller, 2010). 
  
The dissolution profile of CUR-CRS-FD and CUR-HPH-FD samples did not show any remarkable change compared to untreated 
CUR, although a small enhancement could be seen similar to saturation solubility results.  
 
3.8. Re-dispersibility in water 
Amount of re-dispersibility of lipophilic drugs in water shows the accurate predictions of solubility and dissolution as the first step of 
absorption in gastrointestinal tract. In this test re-dispersion of samples recorded by camera after the powder was placed on the surface 
of distilled water in a beaker. As shown in fig 8A the CUR CRS-FD did not re-dispersed in water like untreated CUR due to its high 
lipophilic nature however CUR-HPH-FD sample re-dispersed easily and became wet better than other samples. Fig 8B and C showed 
the HPH samples prepared with 25% POL and 25% SOL re-dispersed in water easily. The orange color of water illustrated this 
phenomenon as well. This test as visual study resulted the ability of HPH samples to be dispersed and wet in water. These results are 
in good agreement with saturation solubility and dissolution studies. The obtained results can be supported by the research work 
carried out by Donsi et al (2010). In previous study CUR sub-micron dispersions have been prepared by high pressure homogenization 
of pure CUR. The resulted CUR shows better water dispersity compare to untreated CUR. The mechanism has been expressed behind 
this results was reduction of CUR particle size and reduction of crystallinity caused by mechanical stress (Donsi et al., 2010). It seems 
in this study we have the same condition moreover the presence of stabilizers (hydrophilic polymers) could enhance re-dispersibility 
of CUR by surfactant properties.    
 
4. Conclusion 
It was shown that antisolvent crystallization of curcumin with acetone and water as solvent and antisolvent produced curcumin 
polymorph with different physicochemical properties. Soluplus and poloxamer 188 are potential stabilizers to be used in antisolvent 
crystallization followed by high pressure homogenization to produce nanoparticles with higher dissolution velocity. High pressure 
homogenization could be more effective than others in producing very fine particle size of curcumin nanoparticles and as a result more 
  
effective in enhancing the solubility and dissolution of curcumin. Sample crystalized and homogenized with 50% soluplus 
(CUR:SOL50% HPH-FD) exhibited about 16-fold higher solubility compare to untreated curcumin. 
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Figures captions 
Figure 1. Optical microscope image of (A) curcumin obtained from anti solvent crystallization (CUR-CRS), (B) curcumin obtained from anti 
solvent crystallization at presence of 5% soluplus, (C) curcumin obtained from anti solvent crystallization followed by high pressure 
homogenization at presence of 5% soluplus.   
Figure 2. SEM image of (A) untreated curcumin, (B) CRS-FD samples with 5% soluplus, (C) HPH-FD samples with 5% soluplus, (D) CRS-FD 
samples with 5% poloxamer, (E) HPH-FD samples with 5% poloxamer. 
Figure 3. Saturation solubility of untreated curcumin, samples prepared with physical mixture (PM), freeze dried samples prepared by antisolvent 
crystallization (CRS-FD) and freeze dried samples prepared by antisolvent crystallization followed by high pressure homogenization (HPH-FD). 
Figure 4. DSC traces of pure CUR, physical mixture (PM), freeze dried samples prepared by antisolvent crystallization (CUR CRS-FD) and 
freeze dried samples prepared by antisolvent crystallization in the presence of 50% of soluplus or poloxamer. 
Figure 5. XRPD pattern of untreated CUR, samples prepared by antisolvent crystallization (CRS-FD) and samples prepared by antisolvent 
crystallization followed by high pressure homogenization (HPH-FD) in the presence of 50% of soluplus or poloxamer. 
Figure 6. FT-IR spectra of untreated CUR, samples obtained through antisolvent crystallization techniques (CRS) in the presence of 50% soluplus 
or poloxamer. 
Figure 7. Dissolution profiles for different samples: (A, B) physical mixtures of CUR and stabilizers, (C,D) freeze dried samples prepared by 
antisolvent crystallization with stabilizers, (E,F) freeze dried samples prepared by antisolvent crystallization followed by high pressure 
homogenization of CUR and stabilizers (HPH-FD). (n = 3, and error bars are standard deviation). 
Figure 8. Re-dispersibility of different samples in water. (A) without stabilizer, (B) with 25% poloxamer, (C) with 25% soluplus.  
  
  
  
Table 1. Particle size of untreated CUR and CUR:SOL/POL samples prepared by different procedures 
 
 
  
SAMPLE z-average 
CRS  
(nm) 
PdI Zeta-
potential 
z-average 
HPH  
(nm) 
PdI z-average 
CRS-FD 
(nm) 
PdI z-average 
HPH-FD 
(nm) 
PdI 
CUR ND ND -31 ND ND ND ND ND ND 
POL 5% 311 ± 82 0.425 ± 0.041 -30 701 ± 89 0.571 ± 0.121 1296 ± 601 0.712 ± 0.122 1021 ± 452 0.651 ± 0.089 
POL 10% 259 ± 42 0.366 ± 0.052 -23 543 ± 54 0.459 ± 0.062 2399 ± 423 1 1333 ±369 0.538 ± 0.092 
POL 25% 396 ± 35 0.463 ± 0.067 -29 475 ± 71 0.371 ± 0.059 1421 ± 398 0.491 ± 0.072 1399 ± 569 1 
POL 50% 339 ± 57 0.293 ± 0.051 -19 616 ± 64 0.416 ± 0.081 1761 ± 405 0.727 ± 0.113 815 ± 402 0.662 ± 0.121 
SOL 5% 258 ± 48 0.305 ± 0.059 -23 491 ±75 0.579 ± 0.066 2026 ± 367 1 1053 ± 825 0.526 ± 0.106 
SOL 10% 218 ± 55 0.325 ± 0.046 -21 778 ± 109 0.601 ± 0.089 6515 ± 536 0.569 ± 0.141 1229 ± 768 0.216 ± 0.075 
SOL 25% 220 ± 38 0.122 ± 0.039 -22 691 ± 97 0.524 ± 0.071 4493 ± 406 1 2739 ± 655 0.562 ± 0.096 
SOL 50% 459 ± 185 0.552 ± 0.041 -12 891 ± 45 0.149 ± 0.052 4033 ± 569 0.469 ± 0.086 3371 ± 504 0.464 ± 0.108 
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Table 2. Dissolution efficiency (DE) and mean dissolution time (MDT) of untreated CUR and 
CUR:SOL/POL samples prepared with physical mixture (PM), antisolvent crystallization (CRS) and 
crystallization followed by high pressure homogenization (HPH). 
Sample 
Theoretical 
loading* 
Actual 
loading
* 
DE40 
% 
MDT 
(min) 
Sample 
Theoretical 
loading 
Actual 
loading 
DE40 
% 
MDT 
(min) 
CUR 100 100 7.81 19.38 CUR 100 100 7.81 19.38 
CUR CRS-FD 100 100 10.93 16.16 CUR CRS-FD 100 100 10.93 16.16 
CUR HPH-FD 100 100 14.34 15.44 CUR HPH-FD 100 100 14.34 15.44 
POL 5% PM 100 100 9.27 13.85 SOL 5% PM 100 100 12.99 12.27 
POL 10% PM 100 100 10.11 12.59 SOL 10% PM 100 100 10.66 19.01 
POL 25% PM 100 100 14.28 15.80 SOL 25% PM 100 100 16.87 11.45 
POL 50% PM 100 100 15.71 14.70 SOL 50% PM 100 100 18.99 14.30 
POL 5% 
 CRS-FD 
95.2 95.3±1.2 
16.71 14.12 SOL 5%  
CRS-FD 
95.2 95.4±2.8 
26.97 13.86 
POL 10% 
CRS-FD 90.9 89.7±1.1 
14.48 17.90 SOL 10%  
CRS-FD 
90.9 90.6±3.1 
37.18 13.27 
POL 25% 
CRS-FD 80 79.1±0.5 
41.49 10.54 SOL 25%  
CRS-FD 
80 79.4±1.9 
41.79 10.46 
POL 50% 
CRS-FD 66.7 66.5±1.4 
59.60 5.19 SOL 50%  
CRS-FD 
66.7 65.9±1.2 
64.47 7.42 
POL 5% 
HPH-FD 95.2 91.7±1.5 
36.22 13.02 SOL 5%  
HPH-FD 
95.2 90.9±0.7 
37.24 8.02 
POL 10% 
HPH-FD 
90.9 80.5±3.8 
35.81 14.52 SOL 10%  
90.9 83.4±2.7 
41.09 8.19 
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 As these are physical mixtures and the drug was added manually, therefore, the value of assay for 
all these physical mixtures should be 100%. 
 
 
  
HPH-FD 
POL 25% 
HPH-FD 80 69.1±2.4 
70.03 7.00 SOL 25%  
HPH-FD 
80 74.1±3.5 
62.37 10.69 
POL 50% 
HPH-FD 66.7 65.6±3.1 
70.50 10.55 SOL 50%  
HPH-FD 
66.7 64.3±1.3 
65.54 13.20 
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